Edge Wealth Management LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Edge Wealth Management LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$490,500
-18.8%
90,0000.0%0.12%
-12.9%
Q2 2023$603,900
-24.1%
90,0000.0%0.13%
-27.5%
Q1 2023$795,150
+18.6%
90,0000.0%0.18%
+16.7%
Q4 2022$670,365
+1.6%
90,0000.0%0.16%
+6.8%
Q3 2022$660,000
-9.3%
90,0000.0%0.15%
-7.0%
Q2 2022$728,000
-41.7%
90,0000.0%0.16%
-36.2%
Q1 2022$1,249,000
-50.5%
90,0000.0%0.25%
-46.8%
Q4 2021$2,525,000
-17.5%
90,0000.0%0.46%
-22.5%
Q3 2021$3,059,000
-16.9%
90,0000.0%0.60%
-20.4%
Q2 2021$3,682,000
+1.6%
90,0000.0%0.75%
-2.7%
Q1 2021$3,623,000
-31.7%
90,0000.0%0.77%
-36.0%
Q4 2020$5,303,000
+21.2%
90,0000.0%1.20%
+19.6%
Q3 2020$4,377,000
+0.5%
90,0000.0%1.01%
+21.9%
Q2 2020$4,354,000
+59.8%
90,000
-10.0%
0.83%
+39.8%
Q1 2020$2,724,000100,0000.59%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders